Capillarisin is primarily studied for its potential therapeutic applications in liver health and cancer treatment. It exhibits strong hepatoprotective properties, helping to protect liver cells from damage caused by toxins and oxidative stress. Due to its anti-inflammatory and antioxidant activities, it is investigated as a supportive agent in treating liver diseases such as hepatitis and non-alcoholic fatty liver disease (NAFLD).

In oncology research, capillarisin shows promise as an anti-cancer compound. It has demonstrated the ability to induce apoptosis and inhibit the growth of various cancer cell lines, particularly in liver and lung cancers. Its mechanism involves disrupting cancer cell cycle progression and suppressing pathways involved in tumor growth and survival.

Additionally, capillarisin is explored for its neuroprotective effects, with studies suggesting it may help reduce neuroinflammation and oxidative damage in brain tissues, indicating potential use in neurodegenerative conditions like Alzheimer’s disease. Most of these applications are still in the preclinical stage, based on in vitro and animal studies.